神经肌肉疾病中无创通气的呼吸辅助技术
本文为叙述性综述,评估成人神经肌肉疾病(NMD)呼吸系统受累时除无创通气(NIV)外的呼吸辅助治疗证据,重点关注肺容积复张(LVR)和机械性吹-排气(MI-E)等辅助肺膨胀和增强咳嗽的技术。证据提示LVR、MI-E及其组合总体有临床效用,但方法学局限削弱了推荐强度并阻碍证据整合。未来试验应前瞻性评估这些技术对长期临床结局和照护负担的影响,并明确获益预测因素。
要点
- NMD呼吸肌受累导致限制性通气障碍和咳嗽无力,NIV是处理低通气和呼吸衰竭的既定疗法。
- LVR和MI-E等辅助肺膨胀和增强咳嗽的技术总体有临床效用,但证据质量有限。
- 未来需前瞻性研究评估LVR和咳嗽增强技术对长期临床结局和照护负担的影响。
核心结论
- LVR、MI-E及其组合在NMD成人中总体有临床效用,但方法学局限限制了临床推荐强度。
研究设计与样本
- 叙述性综述,评估成人NMD伴呼吸系统受累时呼吸治疗的证据。
主要发现
- LVR、MI-E及各种组合总体有临床效用,但重要方法学局限限制临床推荐强度并妨碍证据整合。
临床怎么用
- NIV是管理NMD低通气和呼吸衰竭的既定且不可或缺的疗法。
- LVR和MI-E等辅助技术可考虑用于支持呼吸健康,但需认识证据局限性。
局限性
- 支持其他呼吸治疗效力的证据质量较低,数据质量较差,难以总结。
- 重要方法学局限限制临床推荐强度并妨碍证据整合到实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Muscle weakness is an intrinsic feature of neuromuscular diseases (NMD). When the respiratory muscles are involved, the ability to take a deep breath is compromised, leading to reduced lung volumes and a restrictive ventilatory impairment. Inspiratory, expiratory and bulbar muscle weakness can also impair cough, which may impede secretion clearance. Non-invasive ventilation (NIV) is an established and indispensable therapy to manage hypoventilation and respiratory failure. The role of other therapies that support respiratory health is less clearly defined, and the evidence of efficacy is also harder to summarize as the underlying data are of a lesser quality. This narrative review appraises the evidence for respiratory therapies in adults with NMD and respiratory system involvement. Techniques that assist lung inflation and augment cough, such as lung volume recruitment (LVR) and mechanical insufflation-exsufflation (MI-E), are a particular focus of this review. The evidence suggests that LVR, MI-E and various combinations thereof have clinical utility generally, but important methodological limitations limit the strength of clinical recommendations and hamper the integration of evidence into practice. Future trials should prospectively assess the long-term impact of LVR and cough augmentation on clinical outcomes and burden of care in addition to lung mechanics, as well as determine clear predictors of benefit from these techniques.
引用
- Sheers N, Howard ME, Berlowitz DJ, et al. Respiratory adjuncts to NIV in neuromuscular disease. Respirology. 2018. PMID: 30408263. doi:10.1111/resp.13431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。